Apostolia M Tsimberidou Selected Research

Apostolia M Tsimberidou Research Topics

Disease

104	Neoplasms (Cancer) 02/2022 - 09/2003
12	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2009
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 01/2013
9	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 03/2011
8	Thrombocytopenia (Thrombopenia) 01/2019 - 11/2010
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2017 - 04/2003
7	Melanoma (Melanoma, Malignant) 01/2021 - 01/2014
7	Fatigue 01/2018 - 04/2011
6	Hypertension (High Blood Pressure) 01/2021 - 01/2011
5	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 03/2011
5	Neutropenia 01/2021 - 11/2010
5	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2010
4	Mucositis 01/2021 - 07/2011
4	Exanthema (Rash) 01/2021 - 04/2011
4	Residual Neoplasm 06/2020 - 02/2002
4	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 12/2013
4	Lymphoma (Lymphomas) 07/2006 - 02/2002
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 03/2013
3	Thromboembolism 01/2018 - 01/2011
3	Disease Progression 01/2018 - 06/2016
3	Adenoid Cystic Carcinoma (Cylindroma) 01/2018 - 12/2013
3	Myocardial Infarction 07/2013 - 06/2005
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2005 - 12/2002
2	Hyperglycemia 01/2022 - 10/2016
2	Nausea 01/2022 - 05/2014
2	Carcinogenesis 06/2020 - 08/2018
2	Lung Neoplasms (Lung Cancer) 10/2019 - 05/2013
2	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 02/2010
2	Inflammation (Inflammations) 01/2018 - 05/2014
2	Thyroid Neoplasms (Thyroid Cancer) 01/2018 - 04/2011
2	Anemia 01/2018 - 10/2016
2	Leiomyosarcoma 01/2018 - 12/2016
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2017 - 04/2002
2	Thrombocytosis (Thrombocythemia) 01/2017 - 09/2003
2	Diarrhea 10/2016 - 06/2012
2	Hemorrhage 07/2014 - 07/2013
2	Hypotension (Low Blood Pressure) 01/2011 - 06/2005
2	Bradycardia 01/2011 - 06/2005

Drug/Important Bio-Agent (IBA)

18	Bevacizumab (Avastin)FDA Link 01/2020 - 09/2010
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2013
12	Pharmaceutical PreparationsIBA 01/2022 - 02/2002
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2015 - 01/2008
10	fludarabineIBA 10/2013 - 02/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2011
8	Cetuximab (Erbitux)FDA Link 01/2020 - 02/2013
7	Rituximab (Mabthera)FDA Link 11/2017 - 02/2002
7	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2013 - 04/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2013
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2011
6	MTOR InhibitorsIBA 01/2014 - 03/2012
5	Cell-Free Nucleic AcidsIBA 06/2020 - 01/2016
5	Biological ProductsIBA 06/2020 - 04/2006
5	Monoclonal AntibodiesIBA 01/2020 - 10/2003
5	Lenalidomide (CC 5013)FDA Link 01/2018 - 12/2013
4	Circulating Tumor DNAIBA 01/2022 - 01/2018
4	VemurafenibIBA 01/2021 - 12/2016
4	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 04/2011
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 01/2013
4	temsirolimus FDA Link 04/2016 - 12/2013
4	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2004 - 02/2002
4	Dexamethasone (Maxidex)FDA LinkGeneric 04/2003 - 02/2002
3	selinexorIBA 02/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2018
3	Everolimus FDA Link 01/2021 - 05/2014
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 09/2003
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 07/2011
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017 - 03/2009
3	Irinotecan (Camptosar)FDA LinkGeneric 12/2016 - 10/2013
3	Cisplatin (Platino)FDA LinkGeneric 10/2013 - 04/2002
3	Leucovorin (Folinic Acid)FDA Link 02/2013 - 09/2010
3	Fluorouracil (Carac)FDA LinkGeneric 02/2013 - 09/2010
3	Hemoglobins (Hemoglobin)IBA 03/2012 - 10/2007
3	Gemtuzumab (Mylotarg)FDA Link 06/2005 - 12/2002
2	Pemetrexed (MTA)FDA Link 02/2022 - 12/2002
2	Carboplatin (JM8)FDA LinkGeneric 02/2022 - 01/2019
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 02/2015
2	CrizotinibIBA 01/2021 - 01/2018
2	Hormones (Hormone)IBA 01/2021 - 12/2019
2	pembrolizumabIBA 01/2021 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2018
2	Vorinostat FDA Link 01/2020 - 10/2016
2	Proteasome InhibitorsIBA 01/2020 - 01/2019
2	Histone Deacetylase InhibitorsIBA 01/2020 - 10/2016
2	Transaminases (Aminotransferases)IBA 12/2019 - 12/2013
2	Alkaline PhosphataseIBA 12/2019 - 03/2009
2	CreatinineIBA 01/2019 - 10/2007
2	Proteins (Proteins, Gene)FDA Link 09/2018 - 01/2018
2	IpilimumabIBA 01/2018 - 01/2018
2	Dasatinib (BMS 354825)FDA Link 01/2018 - 04/2009
2	Formaldehyde (Formol)FDA Link 01/2016 - 09/2015
2	ParaffinIBA 01/2016 - 09/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2014 - 03/2009
2	AlbuminsIBA 05/2012 - 10/2007

Therapy/Procedure

73	Therapeutics 01/2022 - 12/2002
15	Drug Therapy (Chemotherapy) 01/2022 - 12/2002
9	Precision Medicine 01/2022 - 01/2013
9	Immunotherapy 01/2021 - 04/2015
4	Time-to-Treatment 07/2017 - 02/2015
2	Drug Tapering 01/2018 - 04/2015
2	Investigational Therapies (Experimental Therapy) 07/2015 - 05/2014